Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview of Alexandre Fraichard, CEO, Genoway
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview of Alexandre Fraichard, CEO, Genoway
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
"Join Mr. John Lai, CEO & President of PetVivo Holdings, Inc., for a revealing interview on the company's pioneering advancements and strategic vision."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Economic Recession Trends: From Historical Convulsions to Modern Stability|Taylor and Judd
00:10:00
Metals Australia Advances Lac Rainy Graphite Project| JON DUGDALE , Technical Advisor of Metals Australia Limited
00:10:00
CEO Keith Barron was interviewed for Smallcap Power | Keith Barron, PhD, CEO, President and Chairman, Aurania Resources Ltd. (IE)
00:10:00
Investigative efforts yield remarkable outcomes in Argentina | Arvind Misra, MD, Belararox Limited (IE)
00:00:00
Jonathan N. Johnson, M.D. Pediatric Cardiologist, Mayo Clinic / Mayo Clinic Explains Congenital Heart Defects
00:10:00
Daniel Pipes on the Core of Islam and its Historical Aggressiveness|Daniel Pipes
00:10:00
Blake Waltrip on A2 Milk’s Scientific Backing and Market Potential in the U.S. | Blake Waltrip, CEO , A2 Milk Company.
00:10:00
Peter Thiels AI Investment Strategy|Peter Thiel,Managing Partner,Founders Fund
00:10:00
Q&A Session Highlights: Integrating Coastal and Inland Flood Modeling, Public Tools, and Policy Interactions
00:10:00
We offer objective and knowledge driven coverage and in-depth analysis of a broad range of markets.|Jeffrey S. Cohen,Managing Director,Ladenburg Thalmann & Company Research Division
00:10:00
Culpeo Minerals Strikes 169-Metre Copper Intersection at Lana Corina in Chile's Atacama Desert | Max Tuesley, Managing Director , Culpeo Mineral Plc.